ACLS AXCELIS TECHNOLOGIES INC
FY2025 10-K
AXCELIS TECHNOLOGIES INC (ACLS) filed its fiscal year 2025 10-K annual report with the SEC on Feb 26, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2025 10-K
Business Overview
- • Core business: manufacturer of ion implantation and processing equipment for semiconductor chip fabrication plus aftermarket services
- • No new products or segments introduced; emphasis on systems revenue of $571M in 2025, comprising major portion of total $839M revenue
Management Discussion & Analysis
- • Revenue $839.0M in 2025, down 17.6% YoY from $1,017.9M; product revenue $792.0M (-18.9%), services $47.0M (+14.7%)
- • Gross margin slightly up at 44.9% vs 44.7% in 2024; product gross margin 47.9% vs 46.3%, services margin -5.1% vs 5.4%
Risk Factors
- • U.S. export controls tightening since 2020 on shipments to Chinese chipmakers, including SMIC on the Entity List, threaten 76.0% of system revenue from Asia
- • Geopolitical risk from China-U.S. trade tensions with Chinese customers representing significant revenue, exposing 83.7% of total revenue to potential restrictions
Financial SummaryXBRL
Revenue
$839M
Net Income
$120M
Gross Margin
44.9%
Operating Margin
14.2%
Net Margin
14.3%
ROE
11.6%
Total Assets
$1.4B
EPS (Diluted)
$3.80
Operating Cash Flow
$118M
Source: XBRL data from AXCELIS TECHNOLOGIES INC FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on AXCELIS TECHNOLOGIES INC
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.